Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
source: pixabay.com

 Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations

Dr. Jasvinder Singh, a rheumatologist at Alabama’s University in Birmingham is the author of a study that was featured in Arthritis Care and Research. During a recent interview with MedPageToday,…

Continue Reading  Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
source: pixabay.com

New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment

ChemoCentryx has just announced that they have submitted their New Drug Application to the FDA for a novel ANCA-associated vasculitis therapy. It is called avacopan and it's finally something non-steroidal.…

Continue Reading New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
MRFF Funding Promotes Treatment Development for Patients with Rare Diseases
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/

MRFF Funding Promotes Treatment Development for Patients with Rare Diseases

  When it comes to researching and finding treatments for rare diseases, funding plays a crucial role. Recently, the Medical Research Future Fund (MRFF) Stem Cell Therapies Mission presented Monash…

Continue Reading MRFF Funding Promotes Treatment Development for Patients with Rare Diseases
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
ANCA Vasculitis Could Be Severe Complication of Lemtrada
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

ANCA Vasculitis Could Be Severe Complication of Lemtrada

According to ANCA Vasculitis News, recent research shows that patients with multiple sclerosis who are being treated with Lemtrada are at greater risk of developing severe ANCA vasculitis. The drug therapy…

Continue Reading ANCA Vasculitis Could Be Severe Complication of Lemtrada
Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
source: pixabay.com

Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out

  "A steak saved my life," writes columnist Damon Young, 41, in his article for GQ, as he shares the story of his diagnosis with Takayasu's arteritis. After over-indulging at dinner,…

Continue Reading Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial
source: pixabay.com

Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial

Pyoderma gangraenosum (PG) is a rare auto inflammatory disease which affects the skin. It unfortunately has no currently approved therapies. However, recent preliminary results from a Phase 2a trial have…

Continue Reading Two Pyoderma Gangraenosum Patients Have Experienced Complete Healing in New Trial
A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
source: pixabay.com

A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement

  A recent article in ANCA Vasculitis News highlighted a Chinese study of ANCA-associated vasculitis (AAV), a group of autoimmune diseases. An earlier Chinese study suggested that the risk of…

Continue Reading A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
Researchers are Now Able to Zoom in on the Mutations Causing Autoimmune Diseases
source: pixabay.com

Researchers are Now Able to Zoom in on the Mutations Causing Autoimmune Diseases

Without understanding the cause of disease it is difficult to understand how to most effectively care for patients. Instead of addressing the underlying cause of disease, physicians are forced to…

Continue Reading Researchers are Now Able to Zoom in on the Mutations Causing Autoimmune Diseases
New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients
source: pixabay.com

New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients

According to a story from Healio, new guidelines for the treatment of different forms of vasculitis recommend the use of biologic therapies as a first-line option for certain patients. It…

Continue Reading New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients
The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis
qimono / Pixabay

The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis

According to a story from finanzen.ch, the US Food and Drug Administration (FDA) recently approved the drug rituximab (marketed as Rituxan) as a treatment in child patients aged at least…

Continue Reading The FDA Approves First Pediatric Treatment for Rare Forms of Vasculitis